跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
傷害防治學研究所
臺北醫學大學
公共衛生學院
電話
+886-2-27361661#6579
電子郵件
[email protected]
網站
http://ipc.tmu.edu.tw/main.php
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street,
11031
Taipei
概覽
指紋
網路
專家檔案
(12)
專案
(192)
研究成果
(1069)
資料集
(23)
指紋
查看啟用 傷害防治學研究所 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Nursing and Health Professions
Injury
100%
Traumatic Brain Injury
91%
Confidence Interval
68%
Disability
63%
Rehabilitation Engineering
57%
World Health Organization
54%
Odds Ratio
52%
Quality of Life
42%
Disease
36%
Meta Analysis
35%
Head Injury
33%
Prevalence
32%
Spinal Cord Injury
28%
Emergency Ward
27%
Hazard Ratio
22%
Injury Severity
21%
Cohort Analysis
21%
Systematic Review
21%
Logistic Regression Analysis
21%
International Classification of Functioning, Disability and Health
21%
Psychometry
20%
Drug Therapy
19%
Cross-Sectional Study
19%
Test Retest Reliability
18%
Pilot Study
17%
Body Composition
16%
Internal Consistency
16%
Mortality Rate
15%
Outpatient
15%
Correlation Coefficient
14%
Symptom
14%
Body Mass
14%
Receiver Operating Characteristic
13%
Subacute Care
13%
Comorbidity
12%
Knee Osteoarthritis
12%
National Health Insurance
12%
Adolescent
11%
Supplementation
11%
Teaching Hospital
10%
Body Weight
10%
Health Service
10%
Total Knee Arthroplasty
10%
Bone Density
9%
Survival Rate
9%
Case-Control Study
9%
Robotics
9%
Dizziness
9%
Brain Injury
9%
Diagnosis
9%
Practice Guideline
8%
Injury Severity Score
8%
Tai Chi
8%
Household
8%
Frailty
8%
School-Aged Child
8%
Air Medical Transport
8%
Infection
8%
Glasgow Coma Scale
8%
Breast Cancer
8%
Muscle Strength
8%
Self Care
8%
Placebo
8%
Emergency Care
8%
Out of Hospital Cardiac Arrest
8%
Severe Acute Respiratory Syndrome
8%
Tobacco Smoke
8%
Ovary Polycystic Disease
8%
Glucose
8%
Intensive Care Unit
7%
Elderly Patient
7%
Convergent Validity
7%
Ward
7%
Physical Disability
7%
Health Status
7%
Rehabilitation Center
7%
Patient Safety
7%
Client
7%
Triage
7%
Area under the Curve
7%
Malignant Neoplasm
7%
Hospital
7%
Clinical Outcome
6%
Chronic Disease
6%
Proportional Hazards Model
6%
Hip Fracture
6%
Repetitive Transcranial Magnetic Stimulation
6%
Physiotherapy
6%
Population
6%
Barthel Index
6%
Adverse Event
6%
Obesity
6%
Medline
6%
Institutionalization
6%
Sleep Disorder
6%
Cerebrovascular Accident
6%
Independent Practice Association
6%
Interrater Reliability
6%
Parkinson's Disease
6%
Muscle Mass
6%
Medicine and Dentistry
Injury
87%
Traumatic Brain Injury
65%
Apoplexy
58%
Disability
47%
Disease
37%
Cohort Analysis
36%
Meta-Analysis
35%
Randomized Controlled Trial
34%
Rehabilitation Engineering
31%
Neoplasm
26%
Odds Ratio
24%
Closed Head Injury
23%
Symptom
20%
Hazard Ratio
20%
Emergency Department
19%
Glioblastoma
17%
Drug Therapy
16%
Logistic Regression Analysis
16%
Malignant Neoplasm
15%
Magnetic Resonance Imaging
13%
Mortality Rate
13%
Cyberknife
13%
Injury Severity
12%
Prevalence
12%
Parkinson's Disease
12%
Surgery
12%
Ganglioglioma
11%
Quality of Life
11%
Systematic Review
11%
Hip Fracture
11%
Outpatient
11%
International Classification of Impairments, Disabilities and Handicaps
11%
Breast Cancer
10%
Spinal Cord Injury
10%
Activities of Daily Living
10%
Motor Performance
10%
Infection
10%
Adverse Outcome
10%
Helmet Use
10%
Glasgow Coma Scale
10%
Body Mass Index
10%
Cohort Effect
10%
Radiosurgery
9%
Evacuation
9%
Osteoarthritis
9%
Traffic Accident
9%
Osteoporosis
9%
Brain Injury
8%
Biological Marker
8%
Sepsis
8%
Diagnosis
8%
Survival Rate
8%
Elderly Patient
8%
Monocyte
8%
Stereotactic Radiosurgery
8%
Retrospective Cohort Study
8%
Recurrent Disease
8%
COVID-19
8%
Percutaneous Vertebroplasty
8%
Polycystic Ovary Syndrome
8%
Neck
7%
Neurologic Disease
7%
Brain Ischemia
7%
Knee
7%
Health Care Cost
7%
Cognition
7%
Traumatic Spinal Cord Injury
7%
Computer Assisted Tomography
7%
Retrospective Study
7%
Childbirth
7%
Triage
7%
Proportional Hazards Model
7%
Cardiovascular Disease
6%
Programmed Cell Death
6%
Dizziness
6%
Environmental Factor
6%
Cerebral Hemorrhage
6%
Electrical Brain Stimulation
6%
Middle Age
6%
Bleeding
6%
Scoring System
6%
Brain Tumor
6%
Arm
6%
Vestibular Schwannoma
6%
Plummer-Vinson Syndrome
6%
Gait
6%
Heat Stroke
6%
Supplementation
6%
Hematoma
6%
Body Weight
5%
Combination Therapy
5%
Visual Analog Scale
5%
Extracorporeal Shockwave Therapy
5%
Hearing Impairment
5%
Cancer
5%
Postoperative Complication
5%
Adverse Event
5%
Temozolomide
5%
Cross Sectional Study
5%
Neutrophil
5%
Pharmacology, Toxicology and Pharmaceutical Science
Injury
76%
Traumatic Brain Injury
47%
Disease
44%
Glioblastoma
30%
Cohort Study
27%
Mouse
25%
Randomized Controlled Trial
25%
Head Injury
24%
Neoplasm
23%
Spinal Cord Injury
17%
Malignant Neoplasm
14%
Temozolomide
13%
Diabetes Mellitus
13%
Heat Stroke
12%
Inflammation
11%
Injury Severity
11%
Mortality Rate
11%
Neuroprotective Agent
10%
Prevalence
10%
Peroxisome Proliferator Activated Receptor
9%
Hypoxia
9%
Endothelin 1
9%
Symptom
9%
Nervous System Inflammation
8%
Fatality
8%
Biological Marker
8%
Angiotensin II
8%
Infection
8%
Survival Rate
8%
Comorbidity
7%
Combination Therapy
7%
Adverse Event
7%
Brain Ischemia
7%
Chemotherapy
7%
Insulin Resistance
7%
Glasgow Coma Scale
7%
Hip Fracture
7%
Acute Heart Infarction
6%
Antipsychotic
6%
Cardiovascular Disease
6%
Parkinson's Disease
6%
Antioxidant
6%
Reactive Oxygen Metabolite
6%
Therapeutic Effect
6%
Spine Injury
6%
Prognosis
6%
Pharmacotherapy
6%
Metabolic Disorder
6%
Typical Antipsychotic
6%
Rat Model
6%
Brain Tumor
6%
Liver Cell Carcinoma
6%
Intervertebral Disk Hernia
6%
Heart Infarction
6%
Hyperlipidemia
5%
Tumor Necrosis Factor
5%
Vaccination Policy
5%
Injury Scale
5%
Clinical Trial
5%
Lung Cancer
5%
Methylprednisolone
5%
Ethanol
5%
Mitogen Activated Protein Kinase
5%
Pomalidomide
5%
Neuroprotection
5%
Metabolic Syndrome X
5%
Placebo
5%
Acetylcysteine
5%
Hypoxia Inducible Factor 1
5%
Lactic Acid
5%
Vasculotropin
5%
Reperfusion Injury
5%
Triacylglycerol
5%